Vaccines

17 Jan 2018 First Patient Dosed in a Phase 2 Trial with Transgene’s TG4010 + Nivolumab + Chemotherapy for the First-Line Treatment of Lung Cancer (NSCLC)
16 Jan 2018 Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication
13 Jan 2018 GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
09 Jan 2018 Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squamous Cell Cancer Advances to Phase 2
04 Jan 2018 Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients
03 Jan 2018 Basilea reports start of clinical phase 1 study in collaboration with the U.S. Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma
23 Dec 2017 Altimmune Announces Positive Initial Data from Its HepTcell Phase 1 Study
21 Dec 2017 AIVITA Biomedical Announces First Patient Enrolled in Phase II Clinical Trial for Late-Stage Ovarian Cancer
19 Dec 2017 VBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine
18 Dec 2017 60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine
18 Dec 2017 Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer
13 Dec 2017 TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negative Breast Cancer Funded by U.S. Department of Defense
12 Dec 2017 Aduro Biotech Provides Update on CRS-207 Programs
11 Dec 2017 Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase 1 Trial
07 Dec 2017 Aptinyx Granted Fast Track Designation, Initiates Phase 1 for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder
07 Dec 2017 Vertex Announces Positive Results from Open-Label Phase 3 Study of KALYDECO(R) (ivacaftor) in Children with Cystic Fibrosis Ages 1 to 2 Years
06 Dec 2017 New data supports the safety and efficacy of GSK’s Shingrix in preventing shingles in autologous haematopoietic stem cell transplant patients
05 Dec 2017 100% of Prostate Cancer Patients Completing 31-Week Post-Therapy Exam After Treatment with OncBioMune Immunotherapy Show No Disease Progression
05 Dec 2017 ObsEva Initiates PROLONG, the Phase 2a Clinical Trial of OBE022 in Preterm Labor
05 Dec 2017 Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
04 Dec 2017 Ovid Therapeutics Presents New Data Demonstrating Potential of TAK-935/OV935 as a Novel Treatment for Developmental and Epileptic Encephalopathies at the American Epilepsy Society (AES) Annual Meeting
04 Dec 2017 Sanofi ends development of Clostridium difficile vaccine
29 Nov 2017 Sanofi updates information on dengue vaccine
28 Nov 2017 Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
28 Nov 2017 SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top